Bank Of New York Mellon Corp Inovio Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$541 Trillion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.79 - $1.91 $690,888 - $1.67 Million	874,542 New	874,542 $717 Million
Q4 2022 Feb 14, 2023	BUY	$1.41 - $2.5 $1.26 Million - $2.23 Million	892,538 New	892,538 $1.39 Million
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $277,469 - $466,348	167,150 Added 23.1%	890,755 $1.54 Million
Q2 2022 Aug 15, 2022	SELL	$1.44 - $3.98 $81,806 - $226,103	-56,810 Reduced 7.28%	723,605 $1.25 Million
Q1 2022 May 11, 2022	SELL	$2.97 - $5.2 $9,560 - $16,738	-3,219 Reduced 0.41%	780,415 $2.8 Million
Q4 2021 Feb 11, 2022	SELL	$4.99 - $7.46 $406,739 - $608,072	-81,511 Reduced 9.42%	783,634 $3.91 Million
Q3 2021 Nov 12, 2021	SELL	$7.16 - $9.69 $384,248 - $520,023	-53,666 Reduced 5.84%	865,145 $6.19 Million
Q2 2021 Aug 11, 2021	BUY	$6.23 - $10.03 $1.26 Million - $2.04 Million	203,039 Added 28.37%	918,811 $8.52 Million
Q1 2021 May 13, 2021	BUY	$8.81 - $16.96 $620,823 - $1.2 Million	70,468 Added 10.92%	715,772 $6.64 Million
Q4 2020 Feb 09, 2021	BUY	$8.5 - $12.85 $272,144 - $411,418	32,017 Added 5.22%	645,304 $5.71 Million
Q3 2020 Nov 12, 2020	BUY	$9.57 - $27.05 $73,545 - $207,879	7,685 Added 1.27%	613,287 $7.11 Million
Q2 2020 Aug 12, 2020	BUY	$7.14 - $31.69 $1.92 Million - $8.52 Million	268,797 Added 79.81%	605,602 $16.3 Million
Q1 2020 May 06, 2020	BUY	$2.98 - $14.09 $111,446 - $526,937	37,398 Added 12.49%	336,805 $2.51 Million
Q4 2019 Feb 14, 2020	SELL	$1.97 - $3.72 $148,102 - $279,665	-75,179 Reduced 20.07%	299,407 $988,000
Q3 2019 Nov 07, 2019	SELL	$2.05 - $3.02 $29,763 - $43,847	-14,519 Reduced 3.73%	374,586 $767,000
Q2 2019 Aug 12, 2019	BUY	$2.29 - $4.1 $37,093 - $66,411	16,198 Added 4.34%	389,105 $1.14 Million
Q1 2019 May 14, 2019	BUY	$3.34 - $5.1 $40,343 - $61,602	12,079 Added 3.35%	372,907 $1.39 Million
Q4 2018 Feb 11, 2019	BUY	$3.89 - $6.11 $51,748 - $81,281	13,303 Added 3.83%	360,828 $1.44 Million
Q3 2018 Nov 09, 2018	BUY	$3.92 - $5.58 $26,373 - $37,542	6,728 Added 1.97%	347,525 $0
Q2 2018 Aug 06, 2018	SELL	$3.88 - $5.16 $117,323 - $156,028	-30,238 Reduced 8.15%	340,797 $1.34 Million
Q1 2018 May 15, 2018	BUY	$4.05 - $5.69 $57,915 - $81,367	14,300 Added 4.01%	371,035 $1.75 Million
Q4 2017 Feb 09, 2018	BUY	$4.13 - $6.68 $1.47 Million - $2.38 Million	356,735	356,735 $1.47 Million

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $496M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account